These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 23832510)

  • 1. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
    Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
    Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid-1 Receptor Antagonism Improves Glycemic Control and Increases Energy Expenditure Through Sirtuin-1/Mechanistic Target of Rapamycin Complex 2 and 5'Adenosine Monophosphate-Activated Protein Kinase Signaling.
    Liu J; Godlewski G; Jourdan T; Liu Z; Cinar R; Xiong K; Kunos G
    Hepatology; 2019 Apr; 69(4):1535-1548. PubMed ID: 30506571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.
    Liu J; Zhou L; Xiong K; Godlewski G; Mukhopadhyay B; Tam J; Yin S; Gao P; Shan X; Pickel J; Bataller R; O'Hare J; Scherer T; Buettner C; Kunos G
    Gastroenterology; 2012 May; 142(5):1218-1228.e1. PubMed ID: 22307032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.
    Ussher JR; Koves TR; Cadete VJ; Zhang L; Jaswal JS; Swyrd SJ; Lopaschuk DG; Proctor SD; Keung W; Muoio DM; Lopaschuk GD
    Diabetes; 2010 Oct; 59(10):2453-64. PubMed ID: 20522596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
    Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
    Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance.
    Ussher JR; Folmes CD; Keung W; Fillmore N; Jaswal JS; Cadete VJ; Beker DL; Lam VH; Zhang L; Lopaschuk GD
    PLoS One; 2012; 7(5):e37703. PubMed ID: 22629445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CB
    Drori A; Gammal A; Azar S; Hinden L; Hadar R; Wesley D; Nemirovski A; Szanda G; Salton M; Tirosh B; Tam J
    Elife; 2020 Nov; 9():. PubMed ID: 33210603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane Prevents Hepatic Insulin Resistance by Blocking Serine Palmitoyltransferase 3-Mediated Ceramide Biosynthesis.
    Teng W; Li Y; Du M; Lei X; Xie S; Ren F
    Nutrients; 2019 May; 11(5):. PubMed ID: 31137828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling.
    Tam J; Szanda G; Drori A; Liu Z; Cinar R; Kashiwaya Y; Reitman ML; Kunos G
    Mol Metab; 2017 Oct; 6(10):1113-1125. PubMed ID: 29031713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
    Tam J; Godlewski G; Earley BJ; Zhou L; Jourdan T; Szanda G; Cinar R; Kunos G
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E457-68. PubMed ID: 24381003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats.
    Campana M; Bellini L; Rouch C; Rachdi L; Coant N; Butin N; Bandet CL; Philippe E; Meneyrol K; Kassis N; Dairou J; Hajduch E; Colsch B; Magnan C; Le Stunff H
    Mol Metab; 2018 Feb; 8():23-36. PubMed ID: 29233519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance.
    Tam J; Cinar R; Liu J; Godlewski G; Wesley D; Jourdan T; Szanda G; Mukhopadhyay B; Chedester L; Liow JS; Innis RB; Cheng K; Rice KC; Deschamps JR; Chorvat RJ; McElroy JF; Kunos G
    Cell Metab; 2012 Aug; 16(2):167-79. PubMed ID: 22841573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.
    Osei-Hyiaman D; Liu J; Zhou L; Godlewski G; Harvey-White J; Jeong WI; Bátkai S; Marsicano G; Lutz B; Buettner C; Kunos G
    J Clin Invest; 2008 Sep; 118(9):3160-9. PubMed ID: 18677409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
    Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
    Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide.
    Watt MJ; Barnett AC; Bruce CR; Schenk S; Horowitz JF; Hoy AJ
    Diabetologia; 2012 Oct; 55(10):2741-2746. PubMed ID: 22854889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the serine palmitoyltransferase subunit SPTLC2 by endoplasmic reticulum stress inhibits the hepatic insulin response.
    Kim GT; Devi S; Sharma A; Cho KH; Kim SJ; Kim BR; Kwon SH; Park TS
    Exp Mol Med; 2022 May; 54(5):573-584. PubMed ID: 35513574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CerS1-Derived C
    Turpin-Nolan SM; Hammerschmidt P; Chen W; Jais A; Timper K; Awazawa M; Brodesser S; Brüning JC
    Cell Rep; 2019 Jan; 26(1):1-10.e7. PubMed ID: 30605666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
    Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
    Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.
    Turpin SM; Nicholls HT; Willmes DM; Mourier A; Brodesser S; Wunderlich CM; Mauer J; Xu E; Hammerschmidt P; Brönneke HS; Trifunovic A; LoSasso G; Wunderlich FT; Kornfeld JW; Blüher M; Krönke M; Brüning JC
    Cell Metab; 2014 Oct; 20(4):678-86. PubMed ID: 25295788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
    Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
    Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.